Abbott Laboratories

ABT60

S&P500

$116.68arrow_drop_down0.56%-$0.65

S&P500

ABT60

$116.68

arrow_drop_down0.56%-$0.65

S&P500

Performance History

Key Stats
Open	$117.31
Prev. Close	$117.36
EPS	3.29

Next Earnings Date	Feb 18, 2025

	LOW	HIGH
Day Range	116.27	117.88
52 Week Range	89.67	121.64

Ratios







EPS	3.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Abbott Laboratories (ABT)

Abbott Laboratories, commonly known as Abbott, is an American multinational medical device and health care company. Headquartered in Abbott Park, Illinois, Abbott operates in over 160 countries and employs approximately 109,000 people. The company was founded in 1888 by Dr. Wallace Abbott and initially focused on formulating and selling pharmaceuticals. Over the years, Abbott diversified its business and is now involved in various areas of healthcare, including diagnostics, medical devices, nutrition products, and branded generic pharmaceuticals. Abbott's mission is to improve people's health and well-being through innovative technologies and solutions.

One of Abbott's key strengths is its diverse portfolio of healthcare products. The company's diagnostics segment offers a wide range of tests and instrumentation for laboratories, hospitals, and clinics. Abbott's medical devices business includes products such as cardiovascular devices, diabetes care devices, and vision care products. The company's nutrition segment offers a variety of products for infants, children, and adults, including nutritional drinks and supplements. Additionally, Abbott's pharmaceuticals business develops and sells branded generic drugs.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Robert B. Ford
Headquarters: North Chicago
Employees: 115000
Exchange: NYSE

Keep an eye on Abbott Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Abbott Laboratories's (ABT) price per share?

The current price per share for Abbott Laboratories (ABT) is $116.69. The stock has seen a price change of -$0.66 recently, indicating a -0.56% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Abbott Laboratories (ABT)?

For Abbott Laboratories (ABT), the 52-week high is $121.64, which is 4.24% from the current price. The 52-week low is $89.67, the current price is 30.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Abbott Laboratories (ABT) a growth stock?

Abbott Laboratories (ABT) has shown an average price growth of -6.8% over the past three years. It has received a score of 44 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Abbott Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Abbott Laboratories (ABT) stock price performance year to date (YTD)?

As of the latest data, Abbott Laboratories (ABT) has a year-to-date price change of 6.22%. Over the past month, the stock has experienced a price change of -2.26%. Over the last three months, the change has been 4.28%. Over the past six months, the figure is 13.06%. Looking at a longer horizon, the five-year price change stands at 38.48%.

help

Is Abbott Laboratories (ABT) a profitable company?

Abbott Laboratories (ABT) has a net income of $5.72B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.18% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.75% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $40.11B, although specific revenue growth data is currently not available. The gross profit is $22.13B. Operating income is noted at $6.48B. Furthermore, the EBITDA is $10.59B.

help

What is the market capitalization of Abbott Laboratories (ABT)?

Abbott Laboratories (ABT) has a market capitalization of $202.37B. The average daily trading volume is 116.45, indicating the stock's liquidity and investor engagement.